Statin drug use is not associated with prostate cancer risk in men who are regularly screened.
暂无分享,去创建一个
I. Thompson | P. Goodman | C. Tangen | M. Lucia | H. Parnes | A. Kristal | D. Albanes | E. Platz | E. Klein | M. Neuhouser | W. Figg | C. Till | I. Thompson | Cathee Till
[1] S. Vinker,et al. Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study , 2013, Prostate Cancer and Prostatic Disease.
[2] Chun-Yuh Yang,et al. Statins increase the risk of prostate cancer: A population‐based case–control study , 2011, The Prostate.
[3] B. Caffo,et al. Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study. , 2011, Cancer epidemiology.
[4] Leonard W. D'Avolio,et al. Statins and prostate cancer diagnosis and grade in a veterans population. , 2011, Journal of the National Cancer Institute.
[5] E. Crawford,et al. Effect of Statins on Serum Prostate-specific Antigen Levels. , 2010, Urology.
[6] T. Tammela,et al. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial , 2010, International journal of cancer.
[7] B. Strom,et al. Statin and NSAID use and prostate cancer risk , 2010, Pharmacoepidemiology and drug safety.
[8] D. Boudreau,et al. Statin use and cancer risk: a comprehensive review , 2010, Expert opinion on drug safety.
[9] E. Platz,et al. Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004 , 2010, Cancer Causes & Control.
[10] P. Goodman,et al. Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[11] E. Platz,et al. The influence of statin medications on prostate-specific antigen levels. , 2008, Journal of the National Cancer Institute.
[12] S. Bonovas,et al. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies , 2008, International journal of cancer.
[13] T. Tammela,et al. Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[14] D. Kadmon,et al. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. , 2005, The Journal of urology.
[15] J. Crowley,et al. Implementation of the Prostate Cancer Prevention Trial (PCPT). , 2004, Controlled clinical trials.
[16] Michael M Lieber,et al. Journal Review , 2003, International Society of Hair Restoration Surgery.
[17] D. Siegel,et al. Use of cholesterol-lowering medications in the United States from 1991 to 1997. , 2000, The American journal of medicine.
[18] D. Gordon,et al. Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. , 1998, Archives of internal medicine.
[19] S. Falahatkar,et al. Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males. , 2011, Acta medica Iranica.
[20] J. Lonnqvist,et al. Incidence of cancer and statin usage—Record linkage study , 2010, International journal of cancer.